GIULIO DRAETTA to Genetic Complementation Test
This is a "connection" page, showing publications GIULIO DRAETTA has written about Genetic Complementation Test.
Connection Strength
0.032
-
The SMARCA2/4 ATPase Domain Surpasses the Bromodomain as a Drug Target in SWI/SNF-Mutant Cancers: Insights from cDNA Rescue and PFI-3 Inhibitor Studies. Cancer Res. 2015 Sep 15; 75(18):3865-3878.
Score: 0.032